Greenberg Traurig’s Tel Aviv office has advised on a series of high-value cross-border financings totalling more than USD 50 million, underscoring its key role in connecting Israeli and US markets.

The Tel Aviv and Miami offices represented PriceMDs, a U.S. healthcare technology company specialising in pricing transparency solutions, in securing a USD 20 million senior secured credit facility from BankUnited. The deal was led by Adam Snukal with Thomas R. Martin and Javier M. Sanchez (both in Miami).

The Tel Aviv and New York offices advised Silexion Therapeutics Corp. on both a USD 6 million public offering and a USD 13.17 million at-the-market (ATM) offering; represented Indaptus Therapeutics, Inc. in an upsized USD 2.34 million ATM offering; and guided Clearmind Medicine Inc. through a USD 10 million convertible notes financing facility.

These biotechnology and life sciences transactions enhance the companies’ capital flexibility to advance clinical and strategic programs.

The teams were led by Gary Emmanuel (Shareholder, Tel Aviv) with support from Michael Soumas, Brandon Sloane, Ben Strauss, and Devora Snyder Shefer, alongside cross-office collaboration with colleagues in New York and Miami.